GUO Yinning, DING Lingyu, MIAO Xueyi, JIANG Xiaoman, XU Ting, CHEN Yimeng, XU Qin. Research progress of frailty interventions in gastrointestinal cancer patients[J]. Journal of Clinical Medicine in Practice, 2023, 27(14): 143-148. DOI: 10.7619/jcmp.20223801
Citation: GUO Yinning, DING Lingyu, MIAO Xueyi, JIANG Xiaoman, XU Ting, CHEN Yimeng, XU Qin. Research progress of frailty interventions in gastrointestinal cancer patients[J]. Journal of Clinical Medicine in Practice, 2023, 27(14): 143-148. DOI: 10.7619/jcmp.20223801

Research progress of frailty interventions in gastrointestinal cancer patients

More Information
  • Received Date: December 20, 2022
  • Revised Date: January 02, 2023
  • Available Online: July 30, 2023
  • Frailty is prevalent in gastrointestinal cancer patients and severely affects their recovery. Frailty is reversible and its development can be prevented or reversed through interventions. This paper reviewed the measures, timing and places of interventions for frail gastrointestinal cancer patients, summarized effect evaluation indexes of interventions, and analyzed the hindering factors of interventions in frail gastrointestinal cancer patients, and proposed corresponding countermeasures, aiming to provide a reference for clinical interventions.

  • [1]
    SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
    [2]
    CHIDA K, KAWAZOE A, SUZUKI T, et al. Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti-PD-1 Therapy[J]. Clin Cancer Res, 2022, 28(10): 2110-2117. doi: 10.1158/1078-0432.CCR-22-0041
    [3]
    CLEGG A, YOUNG J, ILIFFE S, et al. Frailty in elderly people[J]. Lancet (London, England), 2013, 381(9868): 752-762. doi: 10.1016/S0140-6736(12)62167-9
    [4]
    GIANNOTTI C, SAMBUCETI S, SIGNORI A, et al. Frailty assessment in elective gastrointestinal oncogeriatric surgery: Predictors of one-year mortality and functional status[J]. J Geriatr Oncol, 2019, 10(5): 716-723. doi: 10.1016/j.jgo.2019.04.017
    [5]
    RETORNAZ F, GUILLEM O, ROUSSEAU F, et al. Predicting chemotherapy toxicity and death in older adults with colon cancer: results of MOST study[J]. Oncologist, 2020, 25(1): e85-e93. doi: 10.1634/theoncologist.2019-0241
    [6]
    GOBBENS R J J, VAN ASSEN M A L M. Associations between multidimensional frailty and quality of life among Dutch older people[J]. Arch Gerontol Geriatr, 2017, 73: 69-76. doi: 10.1016/j.archger.2017.07.007
    [7]
    黄改荣, 刘祥. 老年人衰弱与失能[J]. 中华老年医学杂志, 2019, 38(10): 1085-1087. https://www.cnki.com.cn/Article/CJFDTOTAL-YXSH202210011.htm
    [8]
    DENT E, LIEN C, LIM W S, et al. The asia-pacific clinical practice guidelines for the management of frailty[J]. J Am Med Dir Assoc, 2017, 18(7): 564-575. doi: 10.1016/j.jamda.2017.04.018
    [9]
    DENT E, MORLEY J E, CRUZ-JENTOFT A J, et al. Physical frailty: ICFSR international clinical practice guidelines for identification and management[J]. J Nutr Health Aging, 2019, 23(9): 771-787. doi: 10.1007/s12603-019-1273-z
    [10]
    MESSAOUDI I, WARNER J, NIKOLICH-ZUGICH D, et al. Molecular, cellular, and antigen requirements for development of age-associated T cell clonal expansions in vivo[J]. J Immunol, 2006, 176(1): 301-308. doi: 10.4049/jimmunol.176.1.301
    [11]
    ETHUN C G, BILEN M A, JANI A B, et al. Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology[J]. CA Cancer J Clin, 2017, 67(5): 362-377. doi: 10.3322/caac.21406
    [12]
    王婷婷, 马慧珍, 邓小岚, 等. 血常规中炎症指标与衰弱及衰弱前期的关系[J]. 实用临床医药杂志, 2022, 26(19): 87-91. doi: 10.7619/jcmp.20221443
    [13]
    YOON S L, KIM J A, KELLY D L, et al. Predicting unintentional weight loss in patients with gastrointestinal cancer[J]. J Cachexia Sarcopenia Muscle, 2019, 10(3): 526-535. doi: 10.1002/jcsm.12398
    [14]
    GOMES M J, MARTINEZ P F, PAGAN L U, et al. Skeletal muscle aging: influence of oxidative stress and physical exercise[J]. Oncotarget, 2017, 8(12): 20428-20440. doi: 10.18632/oncotarget.14670
    [15]
    VERMILLION S A, JAMES A, DORRELL R D, et al. Preoperative exercise therapy for gastrointestinal cancer patients: a systematic review[J]. Syst Rev, 2018, 7(1): 103. doi: 10.1186/s13643-018-0771-0
    [16]
    BERKEL A E M, BONGERS B C, KOTTE H, et al. Effects of community-based exercise prehabilitation for patients scheduled for colorectal surgery with high risk for postoperative complications: results of a randomized clinical trial[J]. Ann Surg, 2022, 275(2): e299-e306. doi: 10.1097/SLA.0000000000004702
    [17]
    SIEBER C C. Malnutrition and sarcopenia[J]. Aging Clin Exp Res, 2019, 31(6): 793-798. doi: 10.1007/s40520-019-01170-1
    [18]
    BONNEFOY M, BERRUT G, LESOURD B, et al. Frailty and nutrition: searching for evidence[J]. J Nutr Health Aging, 2015, 19(3): 250-257. doi: 10.1007/s12603-014-0568-3
    [19]
    ARENDS J, BACHMANN P, BARACOS V, et al. ESPEN guidelines on nutrition in cancer patients[J]. Clin Nutr, 2017, 36(1): 11-48. doi: 10.1016/j.clnu.2016.07.015
    [20]
    ACHILLI P, MAZZOLA M, BERTOGLIO C L, et al. Preoperative immunonutrition in frail patients with colorectal cancer: an intervention to improve postoperative outcomes[J]. Int J Colorectal Dis, 2020, 35(1): 19-27. doi: 10.1007/s00384-019-03438-4
    [21]
    RAHI B, AJANA S, TABUE-TEGUO M, et al. High adherence to a Mediterranean diet and lower risk of frailty among French older adults community-dwellers: results from the Three-City-Bordeaux Study[J]. Clin Nutr, 2018, 37(4): 1293-1298. doi: 10.1016/j.clnu.2017.05.020
    [22]
    郤丽娟, 王道荣, 方方, 等. 抑郁在老年胃肠肿瘤患者睡眠与术前衰弱间的中介效应[J]. 实用临床医药杂志, 2021, 25(5): 50-54. doi: 10.7619/jcmp.20201747
    [23]
    张慧嫔, 张海林, 周晓敏, 等. 消化系统肿瘤患者衰弱现状及影响因素[J]. 护理学杂志, 2022, 37(8): 11-15. https://www.cnki.com.cn/Article/CJFDTOTAL-HLXZ202208003.htm
    [24]
    DE RUI M, VERONESE N, TREVISAN C, et al. Changes in frailty status and risk of depression: results from the progetto Veneto anziani longitudinal study[J]. Am J Geriatr Psychiatry, 2017, 25(2): 190-197. doi: 10.1016/j.jagp.2016.11.003
    [25]
    OBEROI D, MARTOPULLO C, BULTZ B D, et al. The effectiveness of a men-only supportive expressive group therapy intervention for psychosocial health outcomes in gastrointestinal cancer patients: a 6-month longitudinal study[J]. Health and quality of life outcomes, 2021, 19(1): 47. doi: 10.1186/s12955-021-01687-y
    [26]
    DEDEYNE L, DESCHODT M, VERSCHUEREN S, et al. Effects of multi-domain interventions in (pre)frail elderly on frailty, functional, and cognitive status: a systematic review[J]. Clin Interv Aging, 2017, 12: 873-896. doi: 10.2147/CIA.S130794
    [27]
    ROMERA-LIEBANA L, ORFILA F, SEGURA J M, et al. Effects of a primary care-based multifactorial intervention on physical and cognitive function in frail, elderly individuals: a randomized controlled trial[J]. J Gerontol A Biol Sci Med Sci, 2018, 73(12): 1688-1674. doi: 10.1093/gerona/glx252
    [28]
    CHIA C L K, MANTOO S K, TAN K Y. 'Start to finish trans-institutional transdisciplinary care': a novel approach improves colorectal surgical results in frail elderly patients[J]. Colorectal Dis, 2016, 18(1): O43-O50. doi: 10.1111/codi.13166
    [29]
    CARLI F, BOUSQUET-DION G, AWASTHI R, et al. Effect of multimodal prehabilitation vs postoperative rehabilitation on 30-day postoperative complications for frail patients undergoing resection of colorectal cancer: a randomized clinical trial[J]. JAMA Surg, 2020, 155(3): 233-242. doi: 10.1001/jamasurg.2019.5474
    [30]
    LUND C M, VISTISEN K K, OLSEN A P, et al. The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)[J]. Br J Cancer, 2021, 124(12): 1949-1958. doi: 10.1038/s41416-021-01367-0
    [31]
    OMMUNDSEN N, WYLLER T B, NESBAKKEN A, et al. Preoperative geriatric assessment and tailored interventions in frail older patients with colorectal cancer: a randomized controlled trial[J]. Colorectal Dis, 2018, 20(1): 16-25. doi: 10.1111/codi.13785
    [32]
    CARLI F, GILLIS C, SCHEEDE-BERGDAHL C. Promoting a culture of prehabilitation for the surgical cancer patient[J]. Acta Oncol, 2017, 56(2): 128-133. doi: 10.1080/0284186X.2016.1266081
    [33]
    HANNA K, DITILLO M, JOSEPH B. The role of frailty and prehabilitation in surgery[J]. Curr Opin Crit Care, 2019, 25(6): 717-722. doi: 10.1097/MCC.0000000000000669
    [34]
    BAIMAS-GEORGE M, WATSON M, ELHAGE S, et al. Prehabilitation in frail surgical patients: a systematic review[J]. World J Surg, 2020, 44(11): 3668-3678. doi: 10.1007/s00268-020-05658-0
    [35]
    WEST M A, LOUGHNEY L, LYTHGOE D, et al. Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study[J]. Br J Anaesth, 2015, 114(2): 244-251.
    [36]
    VAN DER HULST H C, BASTIAANNET E, PORTIELJE J E A, et al. Can physical prehabilitation prevent complications after colorectal cancer surgery in frail older patients[J]. Eur J Surg Oncol, 2021, 47(11): 2830-2840.
    [37]
    ALHAMBRA-BORRÁS T, DURÁ-FERRANDIS E, FERRANDO-GARCÍA M. Effectiveness and estimation of cost-effectiveness of a group-based multicomponent physical exercise programme on risk of falling and frailty in community-dwelling older adults[J]. Int J Environ Res Public Health, 2019, 16(12): 2086.
    [38]
    AGASI-IDENBURG C S, ZUILEN M K, WESTERMAN M J, et al. "I am busy surviving"-Views about physical exercise in older adults scheduled for colorectal cancer surgery[J]. J Geriatr Oncol, 2020, 11(3): 444-450.
    [39]
    NAVIGANTE A, CRESTA MORGADO P, DAUD M L, et al. Physical exercise and fatigue in advanced gastrointestinal cancer during chemotherapy[J]. BMJ Support Palliat Care, 2022: bmjspcare-bmjsp2021-003516.
    [40]
    CHAPMAN E J, MARTINO E D, EDWARDS Z, et al. Practice review: evidence-based and effective management of fatigue in patients with advanced cancer[J]. Palliat Med, 2022, 36(1): 7-14.
    [41]
    CHAN H Y L, CHUI Y Y, CHAN C W H, et al. Exploring the influence of Traditional Chinese Medicine on self-care among Chinese cancer patients[J]. Eur J Oncol Nurs, 2014, 18(5): 445-451.
    [42]
    DIN N U, MOORE G F, MURPHY S, et al. Health professionals'perspectives on exercise referral and physical activity promotion in primary care: findings from a process evaluation of the National Exercise Referral Scheme in Wales[J]. Health Educ J, 2015, 74(6): 743-757.
  • Related Articles

    [1]SUN Jinjie, LI Dandan, WANG Yinmei, LI Weiwei. Systematic evaluation of measurement characteristics of Chinese-version inflammatory bowel disease disability measurement tools[J]. Journal of Clinical Medicine in Practice, 2024, 28(12): 86-91. DOI: 10.7619/jcmp.20241001
    [2]ZHANG Wenhua, LI Li, ZHU Liqun, ZHOU Yingfeng, BU Hongbing, SUN Guofu, ZHANG Wei, RUAN Yuan. Construction of early fluid resuscitation management evaluation system for acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2023, 27(14): 104-108, 114. DOI: 10.7619/jcmp.20231216
    [3]LI Xiang, XUE Chao, ZHANG Liyun, JIANG Liqing, ZHU Hanzhao, ZHAI Meng′en, LIANG Hongliang, YU Shiqiang, LIU Jincheng, DUAN Weixun. Construction of clinical pathway evaluation system for minimally invasive treatment of congenital heart disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(16): 56-60, 65. DOI: 10.7619/jcmp.20221288
    [4]ZHENG Tao, NING Songyi, ZHU Ying. Construction of nursing quality evaluation system for diabetic retinopathy[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 116-119, 123. DOI: 10.7619/jcmp.20213425
    [5]XIE Mengmeng, MA Chunyuan, CAI Zhonglin, LI Hongyan, XU Yan, ZHANG Qin. Correlation of skeletal muscle mass index with nutritional indexes in hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2021, 25(23): 86-88, 94. DOI: 10.7619/jcmp.20211944
    [6]XU Nan, XU Jie, LI Han, QIU Xiujuan, QIAO Lixing. Effect evaluation of perfusion index in full-term neonates with shock[J]. Journal of Clinical Medicine in Practice, 2018, (9): 93-95. DOI: 10.7619/jcmp.201809025
    [7]ZHANG Yana, XUE Juan, SUN Jinhua. Effect of nursing intervention on deep venous thrombosis of lower extremity after gastrointestinal tract cancer surgery[J]. Journal of Clinical Medicine in Practice, 2018, (6): 64-67. DOI: 10.7619/jcmp.201806019
    [8]CHEN Maochun. Research on construction of evaluation indicators system of nursing safety management in operating room[J]. Journal of Clinical Medicine in Practice, 2015, (12): 91-93,100. DOI: 10.7619/jcmp.201512029
    [9]MIAO Weijing, FAN Xiaohong, FENG Qiao, JIANG Lan, XUE Bei, WANG Li, TAO Luning. Establishment of evaluation index system of acute myocardial infarction clinical nursing pathway[J]. Journal of Clinical Medicine in Practice, 2013, (16): 131-133,144. DOI: 10.7619/jcmp.201316051
    [10]WEI Bo, LONG Xiaorong, HUANG Jian, XIAO Zhongcheng. Effect evaluation of comprehensive nursing intervention for patients with oral lichen planus[J]. Journal of Clinical Medicine in Practice, 2013, (10): 117-119. DOI: 10.7619/jcmp.201310043
  • Cited by

    Periodical cited type(16)

    1. 张磊. 达格列净在NAFLD并CHF患者中的应用效果及可能机制. 新疆医学. 2025(01): 68-72 .
    2. 刘凯,陈园园,陈海燕,项学军,乔锐,聂佩. 达格列净对急性心肌梗死合并糖尿病患者经皮冠状动脉介入治疗后糖代谢和心功能的影响. 西北药学杂志. 2024(03): 189-193 .
    3. 刘雪龙,侯卫东,田勇. 二甲双胍联合贝那鲁肽对T2DM患者糖脂代谢及SCGN、Asprosin水平的影响. 中国卫生工程学. 2024(03): 413-416 .
    4. 周颢,罗英杰. 达格列净联合二甲双胍对肥胖2型糖尿病患者糖脂代谢和微炎症状态的影响. 中国民康医学. 2023(08): 138-141 .
    5. 骆景耀,胡义阳. 达格列净治疗2型糖尿病的临床效果及对脂代谢和内脏脂肪的影响. 临床合理用药. 2023(20): 31-33+37 .
    6. 张武健,沓世泽,黄东柱. 达格列净对血糖控制不佳的2型糖尿病患者肾脏保护作用的研究. 糖尿病新世界. 2023(10): 10-13 .
    7. 秦会娟,侯程浩,张茂杰. 达格列净联合二甲双胍缓释片治疗糖尿病合并慢阻肺稳定期患者的效果分析. 糖尿病新世界. 2023(11): 91-94 .
    8. 沈志伟,陈军童,王黎亚. 空腹血糖结合β_2-微球蛋白对糖尿病患者肾功能损伤的诊断效能评价. 中国临床医生杂志. 2023(08): 922-924 .
    9. 王丽,苏钢,洪娟,宣小明. 达格列净对早期糖尿病肾病的疗效观察. 中国医师进修杂志. 2023(10): 930-933 .
    10. 郑良宏,郑新元. SGLT2抑制剂在2型糖尿病患者治疗中的应用. 糖尿病新世界. 2023(21): 107-109+113 .
    11. 王晶,刘易婷,刘哲. 替米沙坦联合瑞舒伐他汀治疗糖尿病合并冠心病对患者外周胰岛素抵抗、糖化血红蛋白、脂蛋白和心肌缺血的影响. 陕西医学杂志. 2022(05): 595-598 .
    12. 李枫. 观察达格列净对血糖控制不达标的超重和肥胖2型糖尿病患者血糖控制效果及BMI和肾功能的影响. 糖尿病新世界. 2022(14): 85-88 .
    13. 徐爽,童慧昕,梁琳琅,孔媛. 二甲双胍、达格列净、利拉鲁肽联合治疗新诊断超重或肥胖2型糖尿病患者临床疗效及安全性. 临床军医杂志. 2022(12): 1252-1254+1257 .
    14. 战玲,宋杰,杨姗姗. 达格列净联合福辛普利治疗高血压合并糖尿病的效果分析. 中国校医. 2022(12): 948-951 .
    15. 郑伟. 达格列净或沙格列汀联合二甲双胍治疗2型糖尿病的临床疗效探讨. 糖尿病新世界. 2021(15): 89-92 .
    16. 林金城. 达格列净对2型糖尿病合并高尿酸血症患者血糖及尿酸的影响. 医学理论与实践. 2021(24): 4270-4272 .

    Other cited types(2)

Catalog

    Article views (196) PDF downloads (12) Cited by(18)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return